What is ProSci?
ProSci Inc operates at the intersection of immunology and advanced biotechnology, specializing in the design and production of custom rabbit monoclonal antibodies. Unlike traditional mouse-based models, the company utilizes the unique immune response of rabbits to generate antibodies with binding affinities that are frequently 10 to 100 times stronger. This technical advantage allows ProSci to address complex research challenges, including small molecule compounds, splice variants, and post-translational modifications.
With over 17 years of operational experience, the firm provides a comprehensive suite of services ranging from polyclonal and monoclonal development to single-domain antibody engineering. Their state-of-the-art facilities are equipped to process diverse immunogens, including synthetic peptides and pathological tissue samples, making them a preferred vendor for researchers focused on vaccine design and therapeutic innovation.
How much funding has ProSci raised?
ProSci has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in ProSci
PPP
Public-Private Partnership
What's next for ProSci?
Following this major strategic investment, ProSci is expected to prioritize the expansion of its laboratory infrastructure and the enhancement of its high-throughput antibody discovery platforms. As the firm transitions through this late-stage growth phase, the focus will likely shift toward increasing production capacity to meet the rising global demand for specialized diagnostic tools and therapeutic candidates.
Furthermore, the company is poised to deepen its integration into the drug discovery pipeline, potentially exploring new partnerships that leverage its unique rabbit-based immune technology. By maintaining its commitment to high-quality technical assistance and customizable project delivery, ProSci is set to maintain its trajectory as a high-authority player in the antibody development market, ensuring that its research-grade products remain at the forefront of scientific advancement.
